Addition of Angiotensin II Type 1 Receptor Blocker to CCR2 Antagonist Markedly Attenuates Crescentic Glomerulonephritis

Autor: Kayoko Miyata, Hiroyuki Kobori, Omar W. Acres, Maki Urushihara, Ryousuke Satou, Naro Ohashi
Rok vydání: 2011
Předmět:
Male
medicine.medical_specialty
Anti-Glomerular Basement Membrane Disease
Receptors
CCR2

Glomerular Mesangial Cell
Blood Pressure
Enzyme-Linked Immunosorbent Assay
Kidney
urologic and male genital diseases
Rats
Inbred WKY

Article
Renin-Angiotensin System
Transforming Growth Factor beta1
Internal medicine
Renin–angiotensin system
Internal Medicine
medicine
Animals
Receptor
Chemokine CCL2
Cell Proliferation
Analysis of Variance
Reverse Transcriptase Polymerase Chain Reaction
urogenital system
Chemistry
Angiotensin II
Macrophages
Monocyte
Kidney metabolism
medicine.disease
Immunohistochemistry
female genital diseases and pregnancy complications
Rats
Disease Models
Animal

medicine.anatomical_structure
Endocrinology
Angiotensin II Type 1 Receptor Blockers
Nephritis
hormones
hormone substitutes
and hormone antagonists
Zdroj: Hypertension. 57:586-593
ISSN: 1524-4563
0194-911X
DOI: 10.1161/hypertensionaha.110.165704
Popis: The monocyte chemoattractant protein-1 (MCP-1)/CC-chemokine receptor 2 (CCR2) pathway plays a critical role in the development of antiglomerular basement membrane (anti-GBM) nephritis. We recently showed angiotensin II (Ang II) infusion in rats activated MCP-1 and transforming growth factor-β1 (TGF-β1), which in turn induced macrophage infiltration of renal tissues. This study was performed to demonstrate that combination therapy with a CCR2 antagonist (CA) and an Ang II type 1 receptor blocker (ARB) ameliorated renal injury in the anti-GBM nephritis model. An anti-GBM nephritis rat model developed progressive proteinuria and glomerular crescent formation, accompanied by increased macrophage infiltration and glomerular expression of MCP-1, angiotensinogen, Ang II, and TGF-β1. Treatment with CA alone or ARB alone moderately ameliorated kidney injury; however, the combination treatment with CA and ARB dramatically prevented proteinuria and markedly reduced glomerular crescent formation. The combination treatment also suppressed the induction of macrophage infiltration, MCP-1, angiotensinogen, Ang II, and TGF-β1 and reversed the fibrotic change in the glomeruli. Next, primary cultured glomerular mesangial cells (MCs) stimulated by Ang II showed significant increases in MCP-1 and TGF-β1 expression. Furthermore, cocultured model consisting of MCs, parietal epithelial cells, and macrophages showed an increase in Ang II-induced cell proliferation and collagen secretion. ARB treatment attenuated these augmentations. These data suggest that Ang II enhances glomerular crescent formation of anti-GBM nephritis. Moreover, our results demonstrate that inhibition of the MCP-1/CCR2 pathway with a combination of ARB effectively reduces renal injury in anti-GBM nephritis.
Databáze: OpenAIRE